Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database.
暂无分享,去创建一个
M. Illario | G. Iolascon | E. Menditto | V. Orlando | F. Gimigliano | I. Riccio | V. Monetti | A. Moretti | M. Di Gennaro
[1] A. Capaldo,et al. Osteoporosis drugs in real-world clinical practice: an analysis of persistence , 2013, Aging Clinical and Experimental Research.
[2] J. V. Boven,et al. Persistence with osteoporosis medication among newly-treated osteoporotic patients , 2013, Journal of Bone and Mineral Metabolism.
[3] J. Adams,et al. Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. , 2012, Bone.
[4] M. Brandi,et al. The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study , 2010, Arthritis research & therapy.
[5] I. Imaz,et al. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis , 2010, Osteoporosis International.
[6] S. Silverman,et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. , 2009, The American journal of medicine.
[7] S. Rietbrock,et al. Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] C. Cooper,et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.
[9] E. Badamgarav,et al. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. , 2007, Mayo Clinic proceedings.
[10] S. Silverman,et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. , 2006, Mayo Clinic proceedings.
[11] S. Giannini,et al. Determinants of adherence to osteoporosis treatment in clinical practice , 2006, Osteoporosis International.
[12] S. Emani,et al. Compliance with pharmacologic therapy for osteoporosis , 2003, Osteoporosis International.
[13] A. Giusti,et al. Persistence with calcium and vitamin D in elderly patients after hip fracture , 2008, Journal of Bone and Mineral Metabolism.
[14] Anuja Roy,et al. Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] A. Scillitani,et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey , 2005, Osteoporosis International.